Pulmonary Targeting of Levofloxacin Using Microsphere-Based Dry Powder Inhalation

Pulmonary Targeting of Levofloxacin Using Microsphere-Based Dry Powder Inhalation

The objective of the current study was to develop poly (lactic-co-glycolic acid) (PLGA) microspheres loaded with the anti-tuberculosis (anti-TB) fluoroquinolone, Levofloxacin (LVX), in the form of dry powder inhalation (DPI). LVX-loaded microspheres were fabricated by solvent evaporation technique....

Full description

Bibliographic Details
Main Authors: Turki Al Hagbani, Bhavya Vishwa, Amr S. Abu Lila, Hadil Faris Alotaibi, El-Sayed Khafagy, Afrasim Moin, Devegowda V. Gowda
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Pharmaceuticals
Subjects:
inhalable microspheres
levofloxacin
lung targeting
pulmonary drug delivery
tuberculosis
Online Access:https://www.mdpi.com/1424-8247/15/5/560

Internet

https://www.mdpi.com/1424-8247/15/5/560

Similar Items